Azeem Latib, MD

Director, Interventional Cardiology & Structural Heart Interventions
Montefiore Medical Center
Scarsdale, New York, United States

Azeem Latib is the Section Head and Director of Interventional Cardiology and Director of Structural Heart Interventions at Montefiore Medical Center in New York. He started his career in South Africa and obtained his specialization in internal medicine and cardiology at Groote Schuur Hospital in the University of Cape Town. Thereafter, he trained in interventional cardiology at San Raffaele Hospital in Milan, where he worked with Antonio Colombo as a senior interventional cardiologist at San Raffaele Hospital and EMO-GVM Centro Cuore Columbus. He is the principal investigator in numerous First-in-Man, CE-mark and international multi-centre studies both in coronary and structural interventions. Dr Latib is a leading expert in complex coronary interventions as well as transcatheter aortic, mitral and tricuspid interventions.

No relationships to disclose

Presentation(s):

• Late-Breaking Clinical Trials | Drug Coated Balloon & Pharma [Non-CME]

  Saturday, March 9, 2024
  2:00 PM – 3:15 PM ET

• Can AR Dedicated Valves Works for LVAD Patients?

  Saturday, March 9, 2024
  3:12 PM – 3:20 PM ET

• Panel Discussion | The Future of AR and Leak Management

  Saturday, March 9, 2024
  3:28 PM – 3:45 PM ET

• TRICUSPID INTERVENTION | PERCUTANEOUS REPAIR VERSUS REPLACEMENT: THE EXPERTS OPINION

  Saturday, March 9, 2024
  4:30 PM – 5:40 PM ET

• Panel Discussion | When Repair and When Replacement

  Saturday, March 9, 2024
  5:00 PM – 5:10 PM ET

• Review | Case of TriClip

  Saturday, March 9, 2024
  5:10 PM – 5:20 PM ET

• Moderated Discussion | Who Should Perform Tricuspid Repair/Replacement and What Will be the Fate of Surgery and Future Technologies for Tricuspid Disease

  Saturday, March 9, 2024
  5:30 PM – 5:40 PM ET

• NEW FRONTIERS IN DCB AND DES FOR THE TREATMENT OF CAD AND PAD [CME] – Supported Through an Educational Grant by Concept Medical, Inc.

  Saturday, March 9, 2024
  7:00 PM – 9:00 PM ET

• Panel Discussion

  Saturday, March 9, 2024
  7:51 PM – 7:56 PM ET

• Panel Discussion

  Saturday, March 9, 2024
  8:18 PM – 8:23 PM ET

• Panel Discussion

  Saturday, March 9, 2024
  8:50 PM – 9:00 PM ET

• RELIEVE-HF | Why RELIEVE-HF will NOT meet the Endpoint

  Sunday, March 10, 2024
  7:27 AM – 7:32 AM ET

• Panel Discussion and Vote

  Sunday, March 10, 2024
  7:32 AM – 7:36 AM ET

• Panel Discussion and Vote

  Sunday, March 10, 2024
  7:49 AM – 7:53 AM ET

• PARADE OF DCB INDICATIONS

  Sunday, March 10, 2024
  10:15 AM – 11:10 AM ET

• Panel Discussion: Will DCB Play a Role for Coronary Application in the US?

  Sunday, March 10, 2024
  10:55 AM – 11:10 AM ET

• Tricuspid Repair & Replacement

  Sunday, March 10, 2024
  1:30 PM – 5:35 PM ET

• PERCUTANEOUS AND SURGICAL TRICUSPID THERAPIES

  Sunday, March 10, 2024
  2:46 PM – 5:35 PM ET

• TTVR Devices Such as Laplace, Topaz, and V-Dyne

  Sunday, March 10, 2024
  4:46 PM – 4:54 PM ET

• Panel Discussion: How Should We Proceed with Tricuspid Valve Interventions and When Should We Intervene?

  Sunday, March 10, 2024
  5:10 PM – 5:35 PM ET

• CARDIOTUBE INTERVIEW - Supira Medical’s Novel Percutaneous Ventricular Assist Device: Low Profile, High Continuous Flow

  Monday, March 11, 2024
  10:15 AM – 10:30 AM ET

• DRUG-COATED BALLOONS IN DAILY PRACTICE: INSIGHTS FROM LATIN AMERICAN EXPERIENCES

  Monday, March 11, 2024
  11:00 AM – 11:45 AM ET

• Panel Discussion: The Direction of Future of Studies of Tricuspid Valve Interventions

  Monday, March 11, 2024
  3:32 PM – 4:08 PM ET

• Novel Coronary Sinus Reducer for Management of Refractory Angina

  Monday, March 11, 2024
  2:20 PM – 2:30 PM ET

• Supira Low Profile MCS

  Monday, March 11, 2024
  5:03 PM – 5:11 PM ET